TLX - Telix
Market cap:around $1B
Biotech focusing on oncology. Has a number of different fields with prostate being most advance and also brain (gbm), renal and bone marrow/rare diseases. They do both diagnosis and treatment. A good quality biotech imo (hence the $1b market cap) with near term results due from a Phase I trial plus a mid cycle meeting with FDA for their Phase III prostate trial. They have a regular news flow with trials starting, patients being enrolled, new partnerships etc. TLX has a global focus with studies in the US, Europe, Asia, Australia etc. At the moment, it is sitting just below a significant retracement level as well as a solid support/resistance level of $3.80. I think it's a good buy at the current level of $3.71 but I'm not tipping it because I'm not confident of it making 25% in 28 days. However, I am confident that it's a solid company and I expect it to be at least double the price by year end. They have an extensive pipeline of imaging and therapy products and should have a commercial product before year end.
- Forums
- ASX - Short Term Trading
- Short Term Trading Weekend Lounge: 5 - 7 Mar
Short Term Trading Weekend Lounge: 5 - 7 Mar, page-15
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)